Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.
Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.
批准号:
10222085
负责人:
Timothy An-thy Chan
金额:
$135.88万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-30 至 2022-08-31
关键词:
2019-nCoVAcuteAdhesionsAffectAngiotensin IIAntibody ResponseAntigen ReceptorsB-Cell ActivationBlood TestsCOVID-19CardiacCardiac MyocytesCardiopulmonaryCardiovascular DiseasesCardiovascular systemCathepsinsCause of DeathCellsCessation of lifeChronicClinicClinicalDataDeltastabDiseaseDistantDown-RegulationEconomicsEndothelial CellsEndotheliumEnrollmentExpression ProfilingFailureFibrosisFoundationsFunctional disorderFutureGene ExpressionGene Expression ProfileGenetic TranscriptionGlucoseGoalsHealth PersonnelHeartHeart DiseasesHeart failureHeterogeneityHumanImmuneImmune System DiseasesImmunologicsImpairmentIn VitroIndividualInfectionInfection preventionInflammationInflammatoryIntegration Host FactorsInterleukin-6InterventionKnowledgeLeft Ventricular DysfunctionLifeLinkLipoproteinsLongitudinal cohortLymphopeniaMagnetic ResonanceMaintenanceMalignant NeoplasmsMeasuresModelingMolecularMolecular ProfilingMorbidity - disease rateNatureNodalOrganOutcomeOxidesPathogenesisPathway interactionsPatientsPermeabilityPhenotypePilot ProjectsPlasmaPlayPneumoniaPublishingRecoveryResearchRiskRisk FactorsRoleScanningSerologic testsSerologicalSeveritiesShapesStimulusSurvivorsSymptomsT-LymphocyteT-Lymphocyte SubsetsTNF geneTechniquesTestingTissuesToxic effectVentricular DysfunctionViralViral PneumoniaVirusWorkadverse outcomebasecardiometabolismcardiovascular disorder riskcohortcoronavirus diseasecytokinecytokine release syndromecytotoxicexperimental studygain of functionhigh riskimmune activationimmune functionimmune healthimmune system functionimprovedinternational centermonocytemortalitymultidisciplinaryneutralizing antibodypopulation healthpreventprognosticprospectiverecruitresilienceresponsesingle cell sequencingtranscription factortranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The objective of this proposal is to understand the immunologic foundations of heart disease which can occur
as a result of COVID19. Cardiac impairment, when it develops is often fatal, and our hypothesis is that the
maintenance of endothelial function is critical to surviving the protracted nature of COVID19 pneumonia,
especially in those with reduced or delayed antibody responses.
Our first aim will be to analyze those differences in immune function which pre-date infection but appear
to impact the risk of fatal COVID. This will be done by enrolling those at high risk for developing COVID19
(frontline healthcare workers), and performing serially assessments of their immunologic function if they develop
COVID. We will specifically investigate the mechanisms that link pre-infection inflammatory pathways to
protective serologic responses and symptom severity and recovery.
Our second aim will be to perform in vitro experiments to assess the requirements for endothelial cell
dysfunction and infectivity. We will compare various inflammatory and cardiovascular stimuli which seem to play
a role in promoting COVID19-related cardiovascular complications.
Our third aim is to characterize immune cells, endothelial cells, and cardiomyocytes in heart tissue from
those with COVID19-induced left ventricular dysfunction. Using single cell sequencing techniques, we will
determine cellular and molecular signatures that characterize the microenvironment of the COVID19-affected
heart, compared to appropriate controls.
Our conceptual model is that pre-existing immune dysfunction 1) reduces the efficiency of neutralizing
antibody responses, and 2) in conjunction with cardiovascular disease risk factors, induces endothelial
downregulation/depletion of nodal regulators which protect against inflammatory insults. This renders
endothelial cells unable to withstand COVID-specific stimuli. Once completed, this study will provide the
necessary information to improve the identification of those at risk for COVID-related heart disease and develop
rationale approaches to improve the improve survival in the setting of COVID.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
-
批准号:10746700
-
项目类别:
-
资助金额:$3.7万
-
财政年份:2023
-
负责人:Timothy An-thy Chan
-
依托单位:
Project 3 Molecular Mechanisms Underlying Therapy Response to Radiation and Immune Checkpoint Blockade
-
批准号:10818969
-
项目类别:
-
资助金额:$6.66万
-
财政年份:2022
-
负责人:Timothy An-thy Chan
-
依托单位:
Administrative Core
-
批准号:10916639
-
项目类别:
-
资助金额:$7.09万
-
财政年份:2022
-
负责人:Timothy An-thy Chan
-
依托单位:
Administrative Core
-
批准号:10916640
-
项目类别:
-
资助金额:$6.66万
-
财政年份:2022
-
负责人:Timothy An-thy Chan
-
依托单位:
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
-
批准号:10875876
-
项目类别:
-
资助金额:$7.09万
-
财政年份:2022
-
负责人:Timothy An-thy Chan
-
依托单位:
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
-
批准号:10704661
-
项目类别:
-
资助金额:$147.36万
-
财政年份:2022
-
负责人:Timothy An-thy Chan
-
依托单位:
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
-
批准号:10526300
-
项目类别:
-
资助金额:$156.62万
-
财政年份:2022
-
负责人:Timothy An-thy Chan
-
依托单位:
Administrative Core
-
批准号:10526301
-
项目类别:
-
资助金额:$9.33万
-
财政年份:2022
-
负责人:Timothy An-thy Chan
-
依托单位:
Project 1 Genetic and Immunologic Mechanisms Underlying Combination Sacituzumab plus Radiation Therapy for Bladder Cancer
-
批准号:10704713
-
项目类别:
-
资助金额:$16.46万
-
财政年份:2022
-
负责人:Timothy An-thy Chan
-
依托单位:
Project 1 Genetic and Immunologic Mechanisms Underlying Combination Sacituzumab plus Radiation Therapy for Bladder Cancer
-
批准号:10526303
-
项目类别:
-
资助金额:$19.32万
-
财政年份:2022
-
负责人:Timothy An-thy Chan
-
依托单位:
Administrative Core
-
批准号:10704708
-
项目类别:
-
资助金额:$24.74万
-
财政年份:2022
-
负责人:Timothy An-thy Chan
-
依托单位:
Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.
-
批准号:10680625
-
项目类别:
-
资助金额:$67.37万
-
财政年份:2020
-
负责人:Timothy An-thy Chan
-
依托单位:
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
-
批准号:10474453
-
项目类别:
-
资助金额:$99.2万
-
财政年份:2020
-
负责人:Timothy An-thy Chan
-
依托单位:
Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.
-
批准号:10706727
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2020
-
负责人:Timothy An-thy Chan
-
依托单位:
TOWARDS PRECISION IMMUNO-ONCOLOGY: UNRAVELING THE GENOMIC DETERMINANTS AND MECHANISMS UNDERLYING IMMUNOTHERAPY EFFICACY AND RESISTANCE
-
批准号:10201107
-
项目类别:
-
资助金额:$16.1万
-
财政年份:2020
-
负责人:Timothy An-thy Chan
-
依托单位:
Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.
-
批准号:10855043
-
项目类别:
-
资助金额:$80.69万
-
财政年份:2020
-
负责人:Timothy An-thy Chan
-
依托单位:
Elucidating and targeting the molecular foundations of IDH Mutant glioma
-
批准号:10168250
-
项目类别:
-
资助金额:$7.49万
-
财政年份:2020
-
负责人:Timothy An-thy Chan
-
依托单位:
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
-
批准号:10252073
-
项目类别:
-
资助金额:$103.33万
-
财政年份:2020
-
负责人:Timothy An-thy Chan
-
依托单位:
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
-
批准号:10682519
-
项目类别:
-
资助金额:$99.2万
-
财政年份:2020
-
负责人:Timothy An-thy Chan
-
依托单位:
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
-
批准号:10264128
-
项目类别:
-
资助金额:$86.57万
-
财政年份:2020
-
负责人:Timothy An-thy Chan
-
依托单位:
海外基金